Simon Beaudoin
11Patents
1h-index
8Co-inventors
39Inventor score
Filing activity: Mar 15, 2017 → Aug 17, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11291717B1 | Covalently modified antigens for improved immune response and/or stability | Emerging Cross-Sectional Technologies | 6 | Active |
| US11612651B2 | Steroid acid-based immunogen enhancers | Human Necessities | 1 | Active |
| US11352437B2 | Conjugates enhancing total cellular accumulation | Chemistry; Metallurgy | 1 | Active |
| US11280965B2 | Multi-clad optical fiber with taper portion, and optical fiber device having same | Physics | 1 | Active |
| US12411797B2 | Interrupt latency and error resilient full-duplex SPI driver | Physics | 0 | Active |
| US12076396B2 | Steroid acid-based immunogen enhancers | Human Necessities | 0 | Active |
| US12150989B2 | Covalently modified antigens for improved immune response and/or stability | Emerging Cross-Sectional Technologies | 0 | Active |
| US12233130B2 | Covalently-modified steroid acid-peptides having enhanced stability and/or biological activity | Chemistry; Metallurgy | 0 | Active |
| US11890350B2 | Steroid acid-peptide based cytotoxic compounds | Chemistry; Metallurgy | 0 | Active |
| US12350346B2 | Conjugates enhancing total cellular accumulation | Chemistry; Metallurgy | 0 | Active |
| US12423254B2 | Interrupt latency resilient UART driver | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.